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was not reported in the paper. Blinding was not possible in this study. The patients were followed up for 1 year and 18 patients were lost to follow-up (10 from the PPI group and 8 from the EGT group). Response rates for the 1-year follow-up questionnaire were 90% for general practitioners (GPs) and 86% for patients.
Analysis of effectiveness
The primary health outcomes used were the number of days with dyspepsia symptoms, and whether patients and their GPs considered that they were free from symptoms at the 1-year follow-up. The authors stated that an intention to treat analysis was undertaken, but the 18 patients lost to follow-up were excluded.
Effectiveness results
In the first 3 months, the number of days without dyspepsia was 75.7 in the PPI group and 76.7 in the EGT group.
Between months 9 and 12, the number of days without dyspepsia was 76.8 in the PPI group and 77.1 in the EGT group.
At 1 year, 21% of patients in the PPI group and 24% of patients in the EGT group indicated that they were free of symptoms.
GPs assessed that 55% of patients in the PPI group and 61% in the EGT group were free from their predominant symptoms.
Clinical conclusions
The authors concluded that EGT was more clinically effective than PPI, but the difference was not statistically significant.
Measure of benefits used in the economic analysis
The health benefit used in the economic analysis was symptom-free days. These data were taken from the RCT.
Direct costs
The direct costs to the health care payer and the patient were included in this study. These covered the costs of diagnostic procedures, H. pylori tests, drugs, GP consultations and patient travel. The resource use data were collected prospectively from the patients included in the RCT. The unit costs of diagnostic procedures and tests were taken from the National Board of Health in Denmark. The unit costs of the drugs were taken from Laegemiddelfortegnelsen (Drug information, Denmark). The unit cost for transport was calculated using a government rate per km. The source of the unit cost of GP consultations was not reported. A breakdown of unit costs and resource use was given in the paper. The price year was 2006.
Statistical analysis of costs
The differences in costs were assessed using t-tests.
Indirect Costs
Productivity costs due to endoscopy, consultations and sick leave were included in this study. Only the costs of those in employment were considered. The resource use data were taken from the study outlined above. The unit costs were derived using mean national wages from Statbank Denmark. A breakdown of the unit costs and resource use was given in the paper. The price year was 2006.
